Vericel Corporation
NASDAQ:VCEL
Overview | Financials
Company Name | Vericel Corporation |
Symbol | VCEL |
Currency | USD |
Price | 59.53 |
Market Cap | 2,938,305,552 |
Dividend Yield | 0% |
52-week-range | 35.78 - 61.49 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Dominick C. Colangelo Esq. |
Website | https://vcel.com |
An error occurred while fetching data.
About Vericel Corporation
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD